Firefly Luciferase (CMV, puromycin) Lentivirus

Luciferase is an enzyme that is catalyzes the oxidation of luciferin to generate bioluminescence. Firefly luciferase refers to the enzyme that was isolated from Photinus pyralis.

This premade lentivirus vector includes both 5’ and 3’ lentiviral LTR and all necessary elements for effective transduction and expression of the target genes as well as antibiotics resistant genes or reporters. A woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) is believed to promote RNA processing events and nuclear export, boosting expression of your gene of interest in target cells by facilitating the production of mature mRNA from transcripts initiated by the virus's internal promoter (e.g. pCMV).

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
LV-CMV-Firefly luciferase ( 2x25 µl )
2x25uL (1x10^8 CFU/mL) In stock
Regular Price:$550.00
On Sale:
LV-CMV-Firefly luciferase ( 8x25 µl )
8x25uL (1x10^8 CFU/mL) In stock
Regular Price:$1,345.00
On Sale:

Product Type: Virus
Product MPN: PLV-10003-50
Biosafety Level: BSL-2
Vector Information: Vector includes both 5? and 3? lentiviral LTR and all necessary elements for effective transduction; woodchuck hepatitis virus posttranscriptional regulatory element (WPRE)
Target Gene / Reporter(s): Firefly luciferase
Promoter: CMV
Selection Gene: puromycin
Virus: LV-CMV-Firefly luciferase
Titer: 1 x 10^8CFU/ml
Storage: Store at -80C. Multiple freeze/thaw cycles not recommended.
Shipped: Dry ice

  1. Newhook TE, Lindberg JM, Adair SJ, Kim AJ, Stelow EB, Rahma OE, Parsons JT, Bauer TW. Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis. Ann Surg Oncol. 2016 Jun;23(6):1993-2000. doi: 10.1245/s10434-016-5116-4. PubMed PMID: 26847682. View Article
  2. Gross BP, Wongrakpanich A, Francis MB, Salem AK, Norian LA. A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer. AAPS J. 2014 Nov;16(6):1194-203. View Article
  3. Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, Mullen MG, Persily JB, Bullock T, Slingluff CL, Ravichandran KS, Parsons JT, Bauer TW. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Clin Cancer Res. 2017 Dec 29. pii: clincanres.2283.2017. doi: 10.1158/1078-0432.CCR-17-2283. View Article

If you publish research with this product, please let us know so we can cite your paper.